
|Videos|March 27, 2017
The Long-Term Impact of Biosimilars
Author(s)Lauren Santye, Assistant Editor
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Advertisement
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy
2
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
3
Bridging Response Emerges as Key Predictor of Cilta-Cel Outcomes in CARTITUDE-4
4
Long-Term BENEFIT Data Affirm Isa-VRd as Standard of Care in Transplant-Ineligible NDMM
5

















































































































































































































